World Top 100 HealthCare Products Companies List by Market Cap as of August 2026

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as of August 2026.

World Largest HealthCare Products Companies in 2026
World Top HealthCare Products Companies by Market Cap in 2026, World Largest HealthCare Products Companies by Market Cap in 2026.

  1. Sunflower Pharmaceutical Group

    World Rank (Aug-2026)
    9,370
    Market Cap (Aug-2026)
    0.975 Billion USD
    World Rank (Jan-05-2024)
    5,480
    Market Cap (Jan-05-2024)
    2.122 Billion USD
    World Rank (Jul-30-2023)
    6,041
    Market Cap (Jul-30-2023)
    1.842 Billion USD
    World Rank (Dec-25-2022)
    5,977
    Market Cap (Dec-25-2022)
    1.723 Billion USD
    World Rank (Jan-07-2022)
    7,405
    Market Cap (Jan-07-2022)
    1.51 Billion USD
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    SUNFLOWER PHARMACEUTICAL GROUP

  2. Kura Oncology

    World Rank (Aug-2026)
    9,405
    Market Cap (Aug-2026)
    0.966 Billion USD
    World Rank (Jan-05-2024)
    7,868
    Market Cap (Jan-05-2024)
    1.161 Billion USD
    World Rank (Jul-30-2023)
    10,368
    Market Cap (Jul-30-2023)
    0.739 Billion USD
    World Rank (Dec-25-2022)
    9,716
    Market Cap (Dec-25-2022)
    0.781 Billion USD
    World Rank (Jan-07-2022)
    10,231
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    67 Million USD
    Annual Operating Income in USD
    -304 Million USD
    Annual Net Income in USD
    -279 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.
    Company Website
    KURA ONCOLOGY

  3. Chemocentryx

    World Rank (Aug-2026)
    9,478
    Market Cap (Aug-2026)
    0.951 Billion USD
    World Rank (Jan-05-2024)
    5,410
    World Rank (Jul-30-2023)
    5,410
    World Rank (Dec-25-2022)
    5,410
    World Rank (Jan-07-2022)
    5,410
    Market Cap (Jan-07-2022)
    2.56 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Operating Income in USD
    -130 Million USD
    Annual Net Income in USD
    -132 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    USA
    Company Profile
    ChemoCentryx is a Biopharmaceutical company. It portfolio of therapeutics in areas such as orphan and rare diseases, chronic kidney disease, immuno oncology and inflammatory and autoimmune diseases. The headquarters is in USA.
    Company Website
    CHEMOCENTRYX

  4. Geron Corporation

    World Rank (Aug-2026)
    9,506
    Market Cap (Aug-2026)
    0.944 Billion USD
    World Rank (Jan-05-2024)
    7,962
    Market Cap (Jan-05-2024)
    1.135 Billion USD
    World Rank (Jul-30-2023)
    6,549
    Market Cap (Jul-30-2023)
    1.618 Billion USD
    World Rank (Dec-25-2022)
    9,612
    Market Cap (Dec-25-2022)
    0.797 Billion USD
    World Rank (Jan-07-2022)
    15,170
    Market Cap (Jan-07-2022)
    0.38 Billion USD
    Annual Operating Income in USD
    -69 Million USD
    Annual Net Income in USD
    -84 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Geron Corporation is a Late Stage Clinical Biopharmaceutical company focused on the development and potential commercialization of a first in class telomerase inhibitor, imetelstat, an innovative therapeutic for hematologic myeloid malignancies. The headquarters is in USA.

    Facts About Company

    Geron Corporation Annual Total Revenue for year ending Dec-2022 was 0.5 million USD and and Net loss for year ending Dec-2022 was -141 million USD.

    Geron Corporation Annual Total Revenue for year ending Dec-2021 was 1.3 million USD and and Net loss for year ending Dec-2021 was =116 million USD.

    As on 2022, Geron Corporation has 107 employees.

    Company Website
    GERON CORPORATION
    Wikipedia
    Wikipedia

  5. Mochida Pharmaceutical

    World Rank (Aug-2026)
    9,510
    Market Cap (Aug-2026)
    0.943 Billion USD
    World Rank (Jan-05-2024)
    9,714
    Market Cap (Jan-05-2024)
    0.811 Billion USD
    World Rank (Jul-30-2023)
    9,555
    Market Cap (Jul-30-2023)
    0.853 Billion USD
    World Rank (Dec-25-2022)
    8,617
    Market Cap (Dec-25-2022)
    0.953 Billion USD
    World Rank (Jan-07-2022)
    8,775
    Market Cap (Jan-07-2022)
    1.13 Billion USD
    Annual Revenue in USD
    804 Million USD
    Annual Net Income in USD
    77 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Japan
    Yahoo @ Tokyo
    Company Profile
    Mochida Pharmaceutical researches, develops, manufactures and sells pharmaceuticals, healthcare products and medical equipment. The company annual revenue is 102,995 million JPY and annual net income is 8,587 million JPY for year ending March 2021. The headquarters is in Japan.
    Company Website
    MOCHIDA PHARMACEUTICAL
    Wikipedia
    Wikipedia

  6. KPC Pharmaceuticals

    World Rank (Aug-2026)
    9,560
    Market Cap (Aug-2026)
    0.933 Billion USD
    World Rank (Jan-05-2024)
    5,278
    Market Cap (Jan-05-2024)
    2.266 Billion USD
    World Rank (Jul-30-2023)
    5,737
    Market Cap (Jul-30-2023)
    2.005 Billion USD
    World Rank (Dec-25-2022)
    6,561
    Market Cap (Dec-25-2022)
    1.498 Billion USD
    World Rank (Jan-07-2022)
    8,078
    Market Cap (Jan-07-2022)
    1.31 Billion USD
    Headquarters Country
    China
    Yahoo @ Shanghai
    Company Website
    KPC PHARMACEUTICALS

  7. Arbutus Biopharma Corporation

    World Rank (Aug-2026)
    9,596
    Market Cap (Aug-2026)
    0.924 Billion USD
    World Rank (Jan-05-2024)
    13,671
    Market Cap (Jan-05-2024)
    0.419 Billion USD
    World Rank (Jul-30-2023)
    14,777
    Market Cap (Jul-30-2023)
    0.361 Billion USD
    World Rank (Dec-25-2022)
    14,340
    Market Cap (Dec-25-2022)
    0.374 Billion USD
    World Rank (Jan-07-2022)
    13,918
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    14 Million USD
    Annual Operating Income in USD
    -38 Million USD
    Annual Net Income in USD
    -34 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    ARBUTUS BIOPHARMA CORPORATION
    Wikipedia
    Wikipedia

  8. Collegium Pharmaceutical

    World Rank (Aug-2026)
    9,617
    Market Cap (Aug-2026)
    0.919 Billion USD
    World Rank (Jan-05-2024)
    8,100
    Market Cap (Jan-05-2024)
    1.103 Billion USD
    World Rank (Jul-30-2023)
    10,025
    Market Cap (Jul-30-2023)
    0.785 Billion USD
    World Rank (Dec-25-2022)
    9,777
    Market Cap (Dec-25-2022)
    0.771 Billion USD
    World Rank (Jan-07-2022)
    11,744
    Market Cap (Jan-07-2022)
    0.66 Billion USD
    Annual Revenue in USD
    781 Million USD
    Annual Operating Income in USD
    180 Million USD
    Annual Net Income in USD
    63 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Collegium Pharmaceutical is a Specialty Pharmaceutical company committed to being the leader in responsible pain management. It has been focused on developing and commercializing new medicines for pain management that reflect its core values and commitment to people suffering from pain, providers and communities. The headquarters is in USA.

    Company Website
    COLLEGIUM PHARMACEUTICAL

  9. Guizhou Bailing Group Pharmaceutical

    World Rank (Aug-2026)
    9,624
    Market Cap (Aug-2026)
    0.918 Billion USD
    World Rank (Jan-05-2024)
    6,586
    Market Cap (Jan-05-2024)
    1.574 Billion USD
    World Rank (Jul-30-2023)
    6,472
    Market Cap (Jul-30-2023)
    1.651 Billion USD
    World Rank (Dec-25-2022)
    5,821
    Market Cap (Dec-25-2022)
    1.796 Billion USD
    World Rank (Jan-07-2022)
    7,194
    Market Cap (Jan-07-2022)
    1.60 Billion USD
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    GUIZHOU BAILING GROUP PHARMACEUTICAL

  10. Cardiovascular Systems

    World Rank (Aug-2026)
    9,625
    World Rank (Jan-05-2024)
    9,625
    World Rank (Jul-30-2023)
    9,625
    Market Cap (Jul-30-2023)
    0.843 Billion USD
    World Rank (Dec-25-2022)
    11,707
    Market Cap (Dec-25-2022)
    0.558 Billion USD
    World Rank (Jan-07-2022)
    11,105
    Market Cap (Jan-07-2022)
    0.74 Billion USD
    Annual Revenue in USD
    236 Million USD
    Annual Operating Income in USD
    -36 Million USD
    Annual Net Income in USD
    -37 Million USD
    Annual Results for Period Ending
    For year ending June-2022
    Headquarters Country
    USA
    Company Profile

    Cardiovascular Systems Developing Innovative Solutions for treating peripheral and coronary artery disease company. It is enhancing current technologies, developing new products, robust medical education, superior clinical evidence and leveraging industry partnerships and broadening end to end cardiovascular intervention solutions to help treat more patients worldwide. The headquarters is in USA.

    Company Website
    CARDIOVASCULAR SYSTEMS INC

Share